181 related articles for article (PubMed ID: 37111759)
1. High-Throughput/High Content Imaging Screen Identifies Novel Small Molecule Inhibitors and Immunoproteasomes as Therapeutic Targets for Chordoma.
Ajay AK; Chu P; Patel P; Deban C; Roychowdhury C; Heda R; Halawi A; Saad A; Younis N; Zhang H; Jiang X; Nasr M; Hsiao LL; Lin G; Azzi JR
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111759
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
[TBL] [Abstract][Full Text] [Related]
3. Impact of CDK Inhibitors on
Bette S; Haase L; Nell J; Grieser T; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TFE; Mellert K
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786326
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
[TBL] [Abstract][Full Text] [Related]
5. Multiple malignant tumors in a patient with familial chordoma, a case report.
Sumransub N; Murugan P; Marette S; Clohisy DR; Skubitz KM
BMC Med Genomics; 2021 Aug; 14(1):213. PubMed ID: 34465320
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
Kim JY; Lee J; Koh JS; Park MJ; Chang UK
J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
[TBL] [Abstract][Full Text] [Related]
7. Identification of repurposed small molecule drugs for chordoma therapy.
Xia M; Huang R; Sakamuru S; Alcorta D; Cho MH; Lee DH; Park DM; Kelley MJ; Sommer J; Austin CP
Cancer Biol Ther; 2013 Jul; 14(7):638-47. PubMed ID: 23792643
[TBL] [Abstract][Full Text] [Related]
8. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
10. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
[TBL] [Abstract][Full Text] [Related]
11. [Chordoma: is there a molecular basis for diagnosis and treatment?].
Scheipl S; Igrec J; Leithner A; Smolle M; Haybäck J; Liegl B
Pathologe; 2020 Mar; 41(2):153-162. PubMed ID: 32100085
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Profiling Supports the Notochordal Origin of Chordoma and Its Dependence on a TGFB1-TBXT Network.
Halvorsen SC; Benita Y; Hopton M; Hoppe B; Gunnlaugsson HO; Korgaonkar P; Vanderburg CR; Nielsen GP; Trepanowski N; Cheah JH; Frosch MP; Schwab JH; Rosenberg AE; Hornicek FJ; Sassi S
Am J Pathol; 2023 May; 193(5):532-547. PubMed ID: 36804377
[TBL] [Abstract][Full Text] [Related]
13. miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence.
Wei W; Zhang Q; Wang Z; Yan B; Feng Y; Li P
Oncol Lett; 2016 Dec; 12(6):4568-4576. PubMed ID: 28105164
[TBL] [Abstract][Full Text] [Related]
14. From notochord formation to hereditary chordoma: the many roles of Brachyury.
Nibu Y; José-Edwards DS; Di Gregorio A
Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
[TBL] [Abstract][Full Text] [Related]
15. Targeting mTOR Pathway in PTEN Deleted Newly Isolated Chordoma Cell Line.
Pagani F; Gryzik M; Somenza E; Cominelli M; Balzarini P; Schreiber A; Mattavelli D; Nicolai P; Doglietto F; Poliani PL
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983607
[TBL] [Abstract][Full Text] [Related]
16. EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
Scheipl S; Barnard M; Cottone L; Jorgensen M; Drewry DH; Zuercher WJ; Turlais F; Ye H; Leite AP; Smith JA; Leithner A; Möller P; Brüderlein S; Guppy N; Amary F; Tirabosco R; Strauss SJ; Pillay N; Flanagan AM
J Pathol; 2016 Jul; 239(3):320-34. PubMed ID: 27102572
[TBL] [Abstract][Full Text] [Related]
17. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
[TBL] [Abstract][Full Text] [Related]
18. AZD8055 enhances in vivo efficacy of afatinib in chordomas.
Zhao T; Siu IM; Williamson T; Zhang H; Ji C; Burger PC; Connis N; Ruzevick J; Xia M; Cottone L; Flanagan AM; Hann CL; Gallia GL
J Pathol; 2021 Sep; 255(1):72-83. PubMed ID: 34124783
[TBL] [Abstract][Full Text] [Related]
19. Molecular features and vulnerabilities of recurrent chordomas.
Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
